S-Allylmercaptocysteine Targets Nrf2 in Osteoarthritis Treatment Through NOX4/NF-κB Pathway
Guang Yang,1 Shui Sun,1 Jian Wang,1 Wei Li,1 Xianquan Wang,1 Lin Yuan,1 Siying Li2 1Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, People’s Republic of China; 2Department of Physiology & Pathophysio...
Main Authors: | Yang G, Sun S, Wang J, Li W, Wang X, Yuan L, Li S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/s-allylmercaptocysteine-targets-nrf2-in-osteoarthritis-treatment-throu-peer-reviewed-article-DDDT |
Similar Items
-
The Effect of Garlic Derivatives (S-Allylmercaptocysteine, Diallyl Disulfide, and S-Allylcysteine) on Gentamicin Induced Ototoxicity: An Experimental Study
by: Lokman Uzun, et al.
Published: (2016-12-01) -
Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
by: Hu X, et al.
Published: (2021-04-01) -
S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling
by: Pingping Luo, et al.
Published: (2021-03-01) -
Tanshinol ameliorates CCl4-induced liver fibrosis in rats through the regulation of Nrf2/HO-1 and NF-κB/IκBα signaling pathway
by: Wang R, et al.
Published: (2018-05-01) -
Salidroside Alleviates Cartilage Degeneration Through NF-κB Pathway in Osteoarthritis Rats
by: Gao H, et al.
Published: (2020-04-01)